Bioinformatically detectable group of novel regulatory oligonucleotides associated with alzheimer's disease and uses thereof
View Patent ↗The present invention relates to a first group of novel oligonucleotides, here identified as genomic address messenger or GAM oligonucleotides, and a second group of novel operon-like polynucleotides, here identified as genomic record or GR polynucleotides. GAM oligonucleotides selectively inhibit translation of known target genes, many of which are known to be involved in various diseases. Nucleic acid molecules are provided respectively encoding 1708 GAM oligonucleotides, and 246 GR polynucleotides as are vectors and probes both comprising the nucleic acid molecules, and methods and systems for detecting GAM oligonucleotides and GR polynucleotide and specific functions and utilities thereof, for detecting expression of GAM oligonucleotides and GR polynucleotides and for selectively enhancing and selectively inhibiting translation of the respective target genes thereof.
1. An isolated nucleic acid selected from the group consisting of:
(a) SEQ ID NO: 6527;
(b) a DNA encoding (a), wherein the DNA is identical in length to (a); and,
(c) the complement of (a) or (b), wherein the complement is identical in length to (a).
2. An isolated nucleic acid selected from the group consisting of:
(a) SEQ ID NO: 15;
(b) nucleotides 80-97 of SEQ ID NO: 6527;
(c) nucleotides 80-98 of SEQ ID NO: 6527;
(d) nucleotides 80-99 of SEQ ID NO: 6527;
(e) nucleotides 80-100 of SEQ ID NO: 6527;
(f) nucleotides 80-102 of SEQ ID NO: 6527;
(g) nucleotides 80-103 of SEQ ID NO: 6527;
(h) a DNA encoding any one of (a)-(g), wherein the DNA is identical in length to (a)-(g), respectively; and
(i) the complement of any one of (a)-(h), wherein the complement is identical in length to (a)-(h), respectively.
3. A vector comprising a human insert, wherein the human insert consists of the nucleic acid of claim 1 , and wherein the vector does not comprise a human insert other than the nucleic acid of claim 1 .
4. A vector comprising a human insert, wherein the human insert consists of the nucleic acid of claim 2 , and wherein the vector does not comprise a human insert other than the nucleic acid of claim 2 .
5. An oligonucleotide probe of 131 nucleotides in length, wherein the probe comprises the nucleic acid of claim 1 .
6. An oligonucleotide probe of 18-24 or 50-120 nucleotides in length, wherein the probe comprises the nucleic acid of claim 2 .